Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MedVest Holdings Corporation was a leading global manufacturer and distributor of critical care medical products, primarily operating through its subsidiary, Medex, Inc. The company specialized in infusion systems, drug administration, pressure monitoring, and respiratory products used in acute care settings such as intensive care units, operating rooms, and catheterization labs. Formed via a management buyout in 2001 and backed by One Equity Partners, MedVest expanded through strategic acquisitions, including Inhalation Plastics and the Jelco intravenous catheter business from Johnson & Johnson. In 2005, the company was acquired by Smiths Medical, a division of Smiths Group, for approximately $925 million, integrating its extensive portfolio of safety-engineered medical devices into Smiths' global operations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MedVest Holdings.